26.95 USD
↗ 0.27 (1.01%)LIVE (AS OF 10:16 AM EST)
Shares of Stoke Therapeutics, Inc. Common Stock (STOK) are trading at $26.95. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, STOK trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.